 "Aarti Drugs dips on weak Q4 results")
Shares of Aarti Drugs dipped 7% to Rs 688 on the BSE after the company reported a 14% year-on-year decline in net profit at Rs 18.86 crore for the fourth quarter ended March 31, 2015 (Q4), on account of lower sales. The pharmaceutical company had posted a profit of Rs 21.95 crore in the same quarter last year.
During the quarter, total operational income of the company declined 1.8% to Rs 278 crore as against Rs 283 crore in the corresponding quarter of the previous fiscal. The EBITDA or operating profit margins were flat at about 15% over the previous year's corresponding quarter.
The stock opened at Rs 698 and touched a low of Rs 676 on the BSE. Till 1048 hours, a combined 143,056 shares changed hands on the counter on the BSE and NSE.
Meanwhile, the stock is among the top performers from the BSE small-cap index in the current calendar year 2015. The stock has rallied 73% so far in 2015, from Rs 427 to Rs 739, compared to a 1% gain in the benchmark S&P BSE Sensex as of yesterday.
During the quarter, total operational income of the company declined 1.8% to Rs 278 crore as against Rs 283 crore in the corresponding quarter of the previous fiscal. The EBITDA or operating profit margins were flat at about 15% over the previous year's corresponding quarter.
The stock opened at Rs 698 and touched a low of Rs 676 on the BSE. Till 1048 hours, a combined 143,056 shares changed hands on the counter on the BSE and NSE.
Meanwhile, the stock is among the top performers from the BSE small-cap index in the current calendar year 2015. The stock has rallied 73% so far in 2015, from Rs 427 to Rs 739, compared to a 1% gain in the benchmark S&P BSE Sensex as of yesterday.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%